Jean-Louis Abitbol

Jean-Louis Abitbol has extensive work experience in the pharmaceutical industry. Jean-Louis is currently semi-retired since May 2019. Prior to that, they held various positions at Inventiva Pharma, including Chief Medical Officer and Head of Development. Jean-Louis also worked as the CMO at Horama and Trophos. Jean-Louis served as the Director of Research, Development and Global Medical Affairs at HRA Pharma. Jean-Louis held the role of Head of Clinical R&D at Pierre Fabre and Pfizer. Before that, they worked at PGRD and Parke-Davis as the Head of Clinical Research. Jean-Louis started their career at Jouveinal as the Group Manager and Head of Clinical Research.

Jean-Louis Abitbol has a comprehensive education history. Jean-Louis attended Université Paris Cité from 1972 to 1979, where they obtained an MD degree. Following that, they pursued further education at the Institut Gustave Roussy from 1980 to 1985. To complement their medical training, they also spent the years 1981 to 1986 at Assistance Publique Hôpitaux de Paris. However, the specific degrees or fields of study for these institutions are not provided.